Edition:
United Kingdom

Tibet Rhodiola Pharmaceutical Holding Co (600211.SS)

600211.SS on Shanghai Stock Exchange

37.39CNY
6:59am GMT
Change (% chg)

¥-0.53 (-1.40%)
Prev Close
¥37.92
Open
¥37.95
Day's High
¥38.15
Day's Low
¥37.16
Volume
661,407
Avg. Vol
998,321
52-wk High
¥56.98
52-wk Low
¥35.02

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- December 18 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.67 1.67

Consensus Estimates Analysis

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Dec-17 3 1,000.05 1,031.16 956.00 1,272.33
Year Ending Dec-18 3 1,129.23 1,224.00 1,002.00 1,641.28
Earnings (per share)
Year Ending Dec-17 3 1.25 1.30 1.23 1.49
Year Ending Dec-18 3 1.45 1.59 1.34 1.83

Historical Surprises

No historical surprise data available.

Consensus Estimates Trend

Sales and Profit Figures in China Yuan Renminbi (CNY)
Earnings and Dividend Figures in China Yuan Renminbi (CNY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Dec-17 1,000.05 1,000.05 1,000.05 1,000.05 1,272.33
Year Ending Dec-18 1,129.23 1,129.23 1,129.23 1,129.23 1,641.28
Earnings (per share)
Year Ending Dec-17 1.25 1.25 1.25 1.27 1.49
Year Ending Dec-18 1.45 1.45 1.45 1.46 1.83

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0
Earnings
Year Ending Dec-17 0 0 0 0
Year Ending Dec-18 0 0 0 0